Hashimoto Thyroiditis: Antibodies Explained & Tracked

TL;DR: Hashimoto is the most common cause of hypothyroidism in iodine-sufficient countries — 5 to 10 percent of women, 1 to 2 percent of men affected. Diagnostically, doctors look at TPO above 100 IU/ml, often Tg above 115 IU/ml, plus a hypoechoic ultrasound pattern. TRAb is negative (otherwise Graves). The lab reference range for TSH goes up to 4.0 mIU/l; TSH, fT3 and fT4 are interpreted by a doctor. For selenium, vitamin D, zinc and other substances, the evidence is limited or mixed.

This article is purely informational and does not replace medical advice, diagnosis or treatment. Hashimoto belongs in endocrinology care. Intake, dose and therapy, including L-thyroxine and supplements, are to be clarified with a doctor. A prescribed therapy is never changed or stopped on your own.

What Hashimoto Actually Is

Hashimoto thyroiditis is a chronic autoimmune disease. The immune system produces antibodies against the body’s own thyroid structures, mainly thyroid peroxidase (TPO) and thyroglobulin (Tg). Over years, these antibodies destroy thyroid tissue. The gland loses production capacity. The endpoint can be hypothyroidism.

The course is not linear. It typically runs through three phases:

1. Euthyroid phase. Antibodies are positive, TSH, fT3 and fT4 still normal. Many patients already have symptoms — fatigue, brain fog, hair loss — even though values are labeled “fine”.
2. Subclinical hypothyroidism. TSH rises to 4.0 to 10 mIU/l, fT3 and fT4 stay in range. Around 5 percent of these cases develop overt hypothyroidism per year.
3. Overt hypothyroidism. TSH above 10 mIU/l, fT4 drops below range. At this stage the doctor decides on treatment with L-thyroxine.

In countries with sufficient iodine supply, Hashimoto is by far the most common cause of hypothyroidism. Women are affected roughly 5 times more often than men. The peak age is 30 to 50. For an overview of the full thyroid panel, read the thyroid values guide.

The 4 Key Antibodies

Hashimoto is not just about TSH. Antibodies are the key to diagnosis and to distinguishing other thyroid conditions.

TPO-Ab is the most important marker. Below 35 IU/ml is normal. Between 35 and 100 IU/ml is borderline — often an early sign, sometimes nonspecific. Above 100 IU/ml makes Hashimoto very likely. Values above 1000 IU/ml are not rare and say little about severity. The trend matters more: does TPO drop over time? Does it stay stable? Does it rise during stressful phases?

Tg-Ab complements the picture. Positive in 60 to 80 percent of Hashimoto patients, sometimes positive alone when TPO is borderline. When both TPO and Tg are positive, the diagnosis is nearly confirmed.

TRAb (TSH receptor antibodies) belong in the initial workup to rule out Graves disease. Graves causes hyperthyroidism, Hashimoto hypothyroidism — the treatments differ considerably. With Hashimoto, TRAb is usually measured once at baseline. Repeated measurement is not needed.

A concrete example: the values show TPO 480 IU/ml, Tg 180 IU/ml, TRAb negative, TSH 3.8 mIU/l, fT3 2.6 pg/ml, fT4 1.1 ng/dl. The pattern: Hashimoto in the euthyroid phase — antibodies clearly elevated, TSH and free hormones still within the reference range. In Lab2go you can plot all five values in one trend and follow over months and years how the antibodies develop.

Symptoms: Why Early Detection Matters

Hashimoto symptoms are nonspecific — which is exactly why the diagnosis often gets missed for years. The most common complaints:

• Persistent fatigue and afternoon energy crashes
• Weight gain without dietary changes
• Hair loss, especially at the outer eyebrows
• Dry skin, brittle nails
• Feeling cold, cold hands and feet
• Constipation, slow digestion
• Depression, low drive, brain fog
• Muscle weakness, joint pain
• Menstrual irregularities
• Puffy face, especially in the morning

The tricky part: each symptom alone is harmless or has many other causes. Only the pattern plus positive antibodies makes the diagnosis. If three or more of these symptoms persist for months, they belong in a medical work-up. TSH plus TPO antibodies is the usual first measurement.

Ultrasound: The Imaging Side

Antibodies are the lab side. Ultrasound is the imaging side. An experienced thyroid specialist often recognizes Hashimoto immediately by three signs:

• Hypoechoic structure. Healthy thyroid tissue is homogeneous and mid-bright on ultrasound. In Hashimoto it turns darker and uneven — the immune system has remodeled the tissue.
• Microcalcifications. Tiny bright dots in the tissue, a consequence of chronic inflammation.
• Volume change. Early Hashimoto can enlarge the gland (goiter), late Hashimoto shrinks it below 8 ml (women) or 12 ml (men).

Ultrasound does not replace antibodies — they complement each other. In unclear cases (borderline TPO, atypical symptoms) it tips the decision. Cost: 50 to 80 euros as a specialist out-of-pocket test.

Triggers: What Sets Off or Worsens Hashimoto

Hashimoto has a genetic component — HLA-DR3 and HLA-DR5 substantially raise risk. But genes alone are not enough. Epigenetic triggers decide whether and when the disease breaks out. The six main ones:

Iodine excess. Very high iodine intake can raise autoimmune activity. Whether iodine-containing products, seaweed powder, potassium iodide products or some sea algae products are suitable with Hashimoto is something to clarify with your doctor.

Selenium deficiency. Selenium is a cofactor of glutathione peroxidase, which protects the thyroid from oxidative stress. European soils are selenium-poor. Serum selenium below 80 µg/l is considered an independent risk factor.

Vitamin D below 30 ng/ml. Vitamin D modulates the immune system. Values below 30 ng/ml go along with a higher Hashimoto risk. More on measured values and the evidence in the vitamin D3+K2 combo guide.

Gut health. Leaky gut, elevated zonulin and gluten sensitivity are associated with Hashimoto. Evidence is not clear-cut but plausible: with barrier dysfunction, antigens enter the bloodstream and can trigger autoimmune processes.

Infections. Epstein-Barr virus (EBV), Yersinia enterocolitica and other pathogens are discussed as triggers. With positive TPO and persistent symptoms, serologic workup can make sense.

Hormonal transitions and chronic stress. Pregnancy, postpartum phase, perimenopause and chronically high cortisol shift the immune balance. Postpartum thyroiditis affects 5 to 10 percent of women after delivery and is often the first Hashimoto flare.

Selenium: What the Evidence Shows

Selenium is the best-studied dietary supplement in Hashimoto. The evidence base is comparatively broad. That says nothing, however, about whether an individual person benefits.

Evidence. Meta-analyses report falling TPO antibodies in trials that gave selenium, but individual trials differ widely. No reliable figure for the size of the drop follows from them, and some participants do not respond at all. If antibody values change, it is after months at the earliest. Follow-up measurements are set by the treating practice.

Myo-inositol combinations. Combination products with myo-inositol and selenium are marketed for Hashimoto. There is no solid source here for an added benefit over selenium alone. This article makes no recommendation to use them.

Risks. At high intake, selenium can become toxic (selenosis with hair loss, brittle nails, garlic breath). Serum selenium can be measured in blood and is interpreted by a doctor. A selenium product should not be taken without medical clarification.

For more on how zinc and selenium are assessed, see the zinc and selenium guide.

Vitamin D, Zinc and Other Substances

Selenium is not the only substance discussed in connection with Hashimoto. Here too, this article reports the state of research and makes no recommendation to use anything.

Vitamin D. Hashimoto patients have above-average rates of vitamin D deficiency. The 25-OH vitamin D level is measured in blood and interpreted by a doctor. Whether and how a low value is corrected is decided by the doctor based on the baseline.

Zinc. Zinc is a cofactor of deiodinases — the enzymes that convert T4 to active T3. Zinc deficiency is associated with poorer conversion. Serum zinc reference: 70 to 120 µg/dl.

Myo-inositol. Sold together with selenium. An additive effect on TSH and antibodies is discussed but is not documented here.

LDN (low-dose naltrexone). A prescription-only drug that is used in Hashimoto only off-label. LDN is described as immunomodulating. The evidence base is limited. Any use comes into question only after a medical decision; this article makes no recommendation on it.

Gluten-free: assess individually. Evidence is mixed. Doctors first test for celiac disease (tissue transglutaminase IgA). If positive, gluten avoidance is medically necessary. If negative, you can discuss with your doctor whether a time-limited gluten-free trial, with TPO and symptoms measured before and after, makes sense.

L-Thyroxine: Context

In overt hypothyroidism, L-thyroxine (levothyroxine) is standard therapy. It is available by prescription only. What the doctor checks and decides:

• Dose and intake schedule: set individually by the treating doctor, not by the patient.
• Interactions: calcium, iron and coffee can affect absorption. Spacing and timing are addressed in the practice.
• Follow-up: TSH, fT3 and fT4 are measured regularly, usually 6 to 8 weeks after an adjustment of the therapy and every 6 months thereafter.

T4 alone or T4 plus T3? Standard therapy is L-thyroxine as pure T4. Some patients never feel well on it — a conversion problem is often discussed. In such cases a combination with T3 (liothyronine) or natural desiccated thyroid (NDT) is considered. That decision always belongs to the endocrinologist. Self-switching is dangerous.

TSH, fT3 and fT4 are monitored under medically supervised treatment; the course is individual and cannot be transferred to others.

Pregnancy and Hashimoto

In pregnancy, targets are tighter. According to the recommendations cited, TSH should stay below 2.5 mIU/l in the first trimester and below 3.0 mIU/l in trimesters 2 and 3. Thyroid hormone needs change during pregnancy, and any adjustment of therapy is made by a doctor only. Untreated hypothyroidism increases the risk of miscarriage, pregnancy complications and cognitive developmental issues in the child.

With Hashimoto and a wish to become pregnant, this should be discussed with a doctor before conception. During pregnancy, gynecologists and endocrinologists measure TSH every 4 to 6 weeks.

Tracking: How to Capture the Course Properly

Hashimoto is a long-term story. Single values say little — the trend over years shows how values develop. Typical follow-up intervals, set by the doctor:

Every 3 months at therapy start: TSH, fT3, fT4. Once stable, stretched to every 6 months.

Annually: TPO, Tg, serum selenium, 25-OH vitamin D, zinc, ferritin. Ferritin matters because iron deficiency can worsen thyroid function in parallel.

Every 2 years: thyroid ultrasound. More often if there are volume changes or nodules.

Record context with every measurement: medication as prescribed by the doctor, pregnancy, new symptoms, major stress phases. In Lab2go you see all markers in one trend and spot patterns you would miss in single values. The trend can support the conversation in the practice; it does not replace it. More on methodology in the understanding blood values guide.

Hashimoto in Context with Other Markers

Hashimoto rarely stands alone. Three connections are especially relevant:

Hashimoto and inflammation. Chronic autoimmune activity can mildly raise CRP. If hs-CRP is above 2 mg/l, triggers like gut health, micronutrient deficiencies and stress are considered in the medical work-up. More in the inflammation markers guide.

Hashimoto and iron. Ferritin below 70 ng/ml is associated with poorer T4-to-T3 conversion. When therapy is adjusted, ferritin is therefore often measured too. Iron can be a missing piece; whether treatment is needed is for the doctor to decide.

Hashimoto and cortisol. Chronically high cortisol can affect TSH and conversion. Under long-term stress, rT3 often rises and fT3 drops even though TSH looks normal.

Summary: Three Steps to Get Started

Hashimoto is a chronic condition that is managed under medical care. Diagnostics, medical treatment and a clean record of the course complement each other.

1. Have the diagnosis confirmed. TSH, fT3, fT4, TPO, Tg, TRAb and thyroid ultrasound. Combined cost: 130 to 200 euros.
2. Clarify treatment with a doctor. Whether L-thyroxine is needed, as well as intake, dose and questions about supplements, belong in the practice. Stress and nutrition can be discussed there too.
3. Document the trend. Thyroid panel every 3 to 6 months, antibodies and micronutrients annually, as the doctor plans. Keep the context.

In Lab2go you can log your values, and the plans and pricing are here. For baseline interpretation of your full labs, read the understanding blood values guide.

This article is purely informational and does not replace medical advice. Hashimoto belongs in specialist care. Intake, dose and therapy of L-thyroxine and other substances are set by a doctor. A prescribed therapy is never stopped on your own — even if you feel well. Self-tracking complements medicine. It does not replace it.